top of page

YUPELRI® INHALATION SOLUTION 175MCG/3ML

Product details

Registration number: SIN16336P

Classification: Prescription Only

Active ingredients: Revefenacin

Strength: 175 mcg /3 ml

Dosage form: SOLUTION

Route: RESPIRATORY (INHALATION)

Registrant: VIATRIS PHARMACEUTICALS PTE. LTD.

ATC code: R03BB08

HSA approval date: 28 September 2021

Manufacturer(s): The Ritedose Corporation (TRC)

Manufacturing country/countries: UNITED STATES

What are the HSA registration number and classification for YUPELRI® INHALATION SOLUTION 175MCG/3ML?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16336P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for YUPELRI® INHALATION SOLUTION 175MCG/3ML?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Revefenacin

Strength: 175 mcg /3 ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for YUPELRI® INHALATION SOLUTION 175MCG/3ML?

According to the HSA dataset updated 7 August 2026:

Dosage form: SOLUTION

Route: RESPIRATORY (INHALATION)

Source for this answer

Who is the recorded registrant for YUPELRI® INHALATION SOLUTION 175MCG/3ML?

According to the HSA dataset updated 7 August 2026:

Registrant: VIATRIS PHARMACEUTICALS PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for YUPELRI® INHALATION SOLUTION 175MCG/3ML?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): The Ritedose Corporation (TRC)

Manufacturing country/countries: UNITED STATES

Source for this answer

Where can I look up YUPELRI® INHALATION SOLUTION 175MCG/3ML in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16336P or the exact product name YUPELRI® INHALATION SOLUTION 175MCG/3ML. The general register link does not preselect this product.

Source for this answer

What are the source dates for this YUPELRI® INHALATION SOLUTION 175MCG/3ML record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this YUPELRI® INHALATION SOLUTION 175MCG/3ML record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16336P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page